HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Seeks $19 Mil. From Cosmetics Firms In User-Fee-Heavy 2014 Budget

This article was originally published in The Rose Sheet

Executive Summary

Collecting user fees from cosmetics manufacturers to the tune of $19 million would help “improve FDA’s capacity to promote greater safety and understanding of cosmetic products,” the agency says. FDA submitted a similar proposal last year and will be up against challenges again in securing the necessary legislation.

Advertisement

Related Content

In Brief: FDA Requests Cosmetics User Fees; Walmart On Ingredient Disclosure
FDA Gets $91 Million Boost, Sequestered User Fees In 2014 Appropriation
FDA’s Cosmetics Site Relaunching In 2014 To Promote Education
PCPC Reaffirms Commitment To FDA Negotiations On Regulatory Overhaul
Safe Cosmetics Act Launches, Aimed At “Regulatory Black Hole”
ICCR Finalizing Nanotech, Trace Impurities Reports Following 6th Meeting
FDA Proposes $19 Mil. In Cosmetics User Fees To Support Enhanced Oversight
Advertisement
UsernamePublicRestriction

Register

RS018492

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel